253 related articles for article (PubMed ID: 29941638)
1. The Orotomide Olorofim Is Efficacious in an Experimental Model of Central Nervous System Coccidioidomycosis.
Wiederhold NP; Najvar LK; Jaramillo R; Olivo M; Birch M; Law D; Rex JH; Catano G; Patterson TF
Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29941638
[TBL] [Abstract][Full Text] [Related]
2. The Novel Fungal Cyp51 Inhibitor VT-1598 Is Efficacious in Experimental Models of Central Nervous System Coccidioidomycosis Caused by Coccidioides posadasii and Coccidioides immitis.
Wiederhold NP; Shubitz LF; Najvar LK; Jaramillo R; Olivo M; Catano G; Trinh HT; Yates CM; Schotzinger RJ; Garvey EP; Patterson TF
Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29437615
[TBL] [Abstract][Full Text] [Related]
3. Dihydroorotate dehydrogenase inhibitor olorofim exhibits promising activity against all clinically relevant species within Aspergillus section Terrei.
Lackner M; Birch M; Naschberger V; Grässle D; Beckmann N; Warn P; Gould J; Law D; Lass-Flörl C; Binder U
J Antimicrob Chemother; 2018 Nov; 73(11):3068-3073. PubMed ID: 30351438
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of Olorofim (F901318) against
Seyedmousavi S; Chang YC; Law D; Birch M; Rex JH; Kwon-Chung KJ
Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30885903
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of olorofim against clinical isolates of the Fusarium oxysporum and Fusarium solani species complexes.
Badali H; Cañete-Gibas C; Patterson H; Sanders C; Mermella B; Garcia V; Mele J; Fan H; Wiederhold NP
Mycoses; 2021 Jul; 64(7):748-752. PubMed ID: 33755988
[TBL] [Abstract][Full Text] [Related]
6. Effect of the Novel Antifungal Drug F901318 (Olorofim) on Growth and Viability of Aspergillus fumigatus.
du Pré S; Beckmann N; Almeida MC; Sibley GEM; Law D; Brand AC; Birch M; Read ND; Oliver JD
Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29891595
[TBL] [Abstract][Full Text] [Related]
7. EUCAST Determination of Olorofim (F901318) Susceptibility of Mold Species, Method Validation, and MICs.
Jørgensen KM; Astvad KMT; Hare RK; Arendrup MC
Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29784842
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo activities of posaconazole against Coccidioides immitis.
González GM; Tijerina R; Najvar LK; Bocanegra R; Rinaldi M; Loebenberg D; Graybill JR
Antimicrob Agents Chemother; 2002 May; 46(5):1352-6. PubMed ID: 11959568
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of VT-1161 for Treatment of Coccidioidomycosis in Murine Infection Models.
Shubitz LF; Trinh HT; Galgiani JN; Lewis ML; Fothergill AW; Wiederhold NP; Barker BM; Lewis ER; Doyle AL; Hoekstra WJ; Schotzinger RJ; Garvey EP
Antimicrob Agents Chemother; 2015 Dec; 59(12):7249-54. PubMed ID: 26369964
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of olorofim (F901318) against clinical isolates of cryptic species of Aspergillus by EUCAST and CLSI methodologies.
Rivero-Menendez O; Cuenca-Estrella M; Alastruey-Izquierdo A
J Antimicrob Chemother; 2019 Jun; 74(6):1586-1590. PubMed ID: 30891600
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of olorofim (F901318) against fungi of the genus, Scedosporium and Rasamsonia as well as against Lomentospora prolificans, Exophiala dermatitidis and azole-resistant Aspergillus fumigatus.
Kirchhoff L; Dittmer S; Buer J; Rath PM; Steinmann J
Int J Antimicrob Agents; 2020 Sep; 56(3):106105. PubMed ID: 32721601
[TBL] [Abstract][Full Text] [Related]
12. Activity of the triazole SCH 56592 against disseminated murine coccidioidomycosis.
Lutz JE; Clemons KV; Aristizabal BH; Stevens DA
Antimicrob Agents Chemother; 1997 Jul; 41(7):1558-61. PubMed ID: 9210684
[TBL] [Abstract][Full Text] [Related]
13.
Seyedmousavi S; Chang YC; Youn JH; Law D; Birch M; Rex JH; Kwon-Chung KJ
Antimicrob Agents Chemother; 2021 Sep; 65(10):e0043421. PubMed ID: 34252298
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of the novel antifungal compound F901318 against Australian Scedosporium and Lomentospora fungi.
Biswas C; Law D; Birch M; Halliday C; Sorrell TC; Rex J; Slavin M; Chen SC
Med Mycol; 2018 Nov; 56(8):1050-1054. PubMed ID: 29370408
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and Associated Drug Exposures of Isavuconazole and Fluconazole in an Experimental Model of Coccidioidomycosis.
Kovanda LL; Sass G; Martinez M; Clemons KV; Nazik H; Kitt TM; Wiederhold N; Hope WW; Stevens DA
Antimicrob Agents Chemother; 2021 May; 65(6):. PubMed ID: 33782009
[No Abstract] [Full Text] [Related]
16. APX001 and Other Gwt1 Inhibitor Prodrugs Are Effective in Experimental
Viriyakosol S; Kapoor M; Okamoto S; Covel J; Soltow QA; Trzoss M; Shaw KJ; Fierer J
Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30455238
[TBL] [Abstract][Full Text] [Related]
17. Correlation between antifungal susceptibilities of Coccidioides immitis in vitro and antifungal treatment with caspofungin in a mouse model.
González GM; Tijerina R; Najvar LK; Bocanegra R; Luther M; Rinaldi MG; Graybill JR
Antimicrob Agents Chemother; 2001 Jun; 45(6):1854-9. PubMed ID: 11353637
[TBL] [Abstract][Full Text] [Related]
18. Activities of the triazole SCH 51048 against Coccidioides immitis in vitro and in vivo.
Clemons KV; Homola ME; Stevens DA
Antimicrob Agents Chemother; 1995 May; 39(5):1169-72. PubMed ID: 7625808
[TBL] [Abstract][Full Text] [Related]
19. Pharmacodynamics of the Orotomides against
Hope WW; McEntee L; Livermore J; Whalley S; Johnson A; Farrington N; Kolamunnage-Dona R; Schwartz J; Kennedy A; Law D; Birch M; Rex JH
mBio; 2017 Aug; 8(4):. PubMed ID: 28830945
[TBL] [Abstract][Full Text] [Related]
20. Comparative efficacies of terbinafine and fluconazole in treatment of experimental coccidioidal meningitis in a rabbit model.
Sorensen KN; Sobel RA; Clemons KV; Calderon L; Howell KJ; Irani PR; Pappagianis D; Williams PL; Stevens DA
Antimicrob Agents Chemother; 2000 Nov; 44(11):3087-91. PubMed ID: 11036027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
